Arch Biopartners Stock Price History
| ARCH Stock | CAD 1.95 0.01 0.51% |
Below is the normalized historical share price chart for Arch Biopartners extending back to May 07, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arch Biopartners stands at 1.95, as last reported on the 2nd of December, with the highest price reaching 1.97 and the lowest price hitting 1.95 during the day.
If you're considering investing in Arch Stock, it is important to understand the factors that can impact its price. Arch Biopartners appears to be risky, given 3 months investment horizon. Arch Biopartners secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2% return per unit of standard deviation over the last 3 months. By analyzing Arch Biopartners' technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please makes use of Arch Biopartners' mean deviation of 2.0, and Risk Adjusted Performance of 0.1515 to double-check if our risk estimates are consistent with your expectations.
At this time, Arch Biopartners' Other Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 2.4 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (4.7 M). . Price To Sales Ratio is likely to drop to 1.78 in 2024. Price Earnings Ratio is likely to drop to -1.48 in 2024. Arch Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.7674 | 50 Day MA 1.8464 | Beta 1.39 |
Arch |
Sharpe Ratio = 0.202
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ARCH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.69 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.54 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Arch Biopartners is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arch Biopartners by adding it to a well-diversified portfolio.
Enterprise Value Ebitda (97.59) | Price Sales 91.9926 | Shares Float 49.8 M | Earnings Share (0.03) | Shares Short 4 K |
Arch Biopartners Stock Price History Chart
There are several ways to analyze Arch Stock price data. The simplest method is using a basic Arch candlestick price chart, which shows Arch Biopartners price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 18, 2024 | 2.14 |
| Lowest Price | September 6, 2024 | 1.5 |
Arch Biopartners December 2, 2024 Stock Price Synopsis
Various analyses of Arch Biopartners' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Arch Stock. It can be used to describe the percentage change in the price of Arch Biopartners from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Arch Stock.| Arch Biopartners Price Rate Of Daily Change | 0.99 | |
| Arch Biopartners Price Daily Balance Of Power | (0.50) | |
| Arch Biopartners Price Action Indicator | (0.02) |
Arch Biopartners December 2, 2024 Stock Price Analysis
Arch Stock Price History Data
The price series of Arch Biopartners for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 0.73 with a coefficient of variation of 10.9. The prices are distributed with arithmetic mean of 1.82. The median price for the last 90 days is 1.88. The company had 1:3 stock split on 25th of November 2003. Arch Biopartners issued dividends on 2000-09-13.| Open | High | Low | Close | Volume | ||
12/02/2024 | 1.96 | 1.97 | 1.95 | 1.95 | ||
| 11/29/2024 | 1.96 | 1.97 | 1.95 | 1.95 | 12,200 | |
| 11/28/2024 | 1.97 | 1.97 | 1.95 | 1.96 | 3,525 | |
| 11/27/2024 | 1.95 | 1.96 | 1.92 | 1.92 | 13,100 | |
| 11/26/2024 | 1.96 | 1.96 | 1.90 | 1.96 | 4,000 | |
| 11/25/2024 | 1.98 | 1.98 | 1.89 | 1.94 | 15,955 | |
| 11/22/2024 | 1.96 | 2.00 | 1.86 | 1.95 | 60,400 | |
| 11/21/2024 | 1.90 | 1.94 | 1.82 | 1.93 | 45,468 | |
| 11/20/2024 | 2.01 | 2.02 | 1.84 | 1.85 | 24,600 | |
| 11/19/2024 | 2.01 | 2.01 | 1.97 | 2.00 | 2,300 | |
| 11/18/2024 | 2.02 | 2.03 | 2.01 | 2.01 | 5,000 | |
| 11/15/2024 | 1.98 | 2.02 | 1.98 | 2.01 | 2,300 | |
| 11/14/2024 | 1.95 | 2.00 | 1.90 | 1.95 | 17,734 | |
| 11/13/2024 | 2.01 | 2.01 | 1.95 | 2.00 | 6,246 | |
| 11/12/2024 | 2.02 | 2.03 | 2.00 | 2.01 | 2,154 | |
| 11/11/2024 | 2.04 | 2.10 | 2.00 | 2.00 | 46,219 | |
| 11/08/2024 | 1.98 | 2.06 | 1.93 | 2.05 | 63,085 | |
| 11/07/2024 | 1.98 | 1.98 | 1.94 | 1.97 | 11,900 | |
| 11/06/2024 | 1.99 | 1.99 | 1.97 | 1.98 | 40,450 | |
| 11/05/2024 | 1.99 | 1.99 | 1.96 | 1.96 | 6,605 | |
| 11/04/2024 | 1.95 | 2.02 | 1.95 | 2.00 | 52,000 | |
| 11/01/2024 | 1.95 | 1.96 | 1.87 | 1.95 | 10,429 | |
| 10/31/2024 | 1.97 | 1.97 | 1.84 | 1.86 | 7,269 | |
| 10/30/2024 | 1.97 | 1.97 | 1.87 | 1.93 | 6,603 | |
| 10/29/2024 | 2.01 | 2.01 | 1.93 | 1.96 | 5,000 | |
| 10/28/2024 | 2.05 | 2.05 | 1.92 | 1.95 | 20,962 | |
| 10/25/2024 | 2.06 | 2.07 | 2.00 | 2.00 | 39,768 | |
| 10/24/2024 | 2.08 | 2.09 | 2.03 | 2.06 | 38,800 | |
| 10/23/2024 | 2.00 | 2.02 | 1.96 | 1.99 | 22,900 | |
| 10/22/2024 | 2.04 | 2.04 | 1.95 | 1.97 | 9,801 | |
| 10/21/2024 | 2.14 | 2.14 | 2.04 | 2.04 | 7,176 | |
| 10/18/2024 | 2.00 | 2.20 | 1.98 | 2.14 | 25,625 | |
| 10/17/2024 | 1.88 | 2.00 | 1.88 | 2.00 | 17,922 | |
| 10/16/2024 | 1.92 | 1.92 | 1.86 | 1.88 | 7,000 | |
| 10/15/2024 | 1.87 | 1.90 | 1.83 | 1.88 | 16,312 | |
| 10/11/2024 | 1.87 | 1.88 | 1.80 | 1.87 | 20,150 | |
| 10/10/2024 | 1.91 | 1.91 | 1.84 | 1.85 | 5,450 | |
| 10/09/2024 | 1.92 | 1.92 | 1.79 | 1.86 | 11,000 | |
| 10/08/2024 | 1.91 | 1.91 | 1.84 | 1.89 | 10,183 | |
| 10/07/2024 | 1.85 | 2.00 | 1.85 | 1.90 | 11,260 | |
| 10/04/2024 | 1.85 | 1.90 | 1.85 | 1.86 | 2,300 | |
| 10/03/2024 | 1.80 | 1.83 | 1.79 | 1.83 | 4,300 | |
| 10/02/2024 | 1.79 | 1.79 | 1.77 | 1.79 | 4,000 | |
| 10/01/2024 | 1.80 | 1.81 | 1.78 | 1.79 | 2,900 | |
| 09/30/2024 | 1.80 | 1.80 | 1.70 | 1.77 | 11,300 | |
| 09/27/2024 | 1.82 | 1.82 | 1.77 | 1.81 | 14,632 | |
| 09/26/2024 | 1.71 | 1.75 | 1.70 | 1.75 | 6,650 | |
| 09/25/2024 | 1.67 | 1.69 | 1.66 | 1.68 | 20,400 | |
| 09/24/2024 | 1.66 | 1.66 | 1.65 | 1.66 | 2,100 | |
| 09/23/2024 | 1.66 | 1.69 | 1.62 | 1.65 | 13,302 | |
| 09/20/2024 | 1.66 | 1.66 | 1.56 | 1.64 | 3,810 | |
| 09/19/2024 | 1.66 | 1.67 | 1.64 | 1.66 | 11,000 | |
| 09/18/2024 | 1.66 | 1.66 | 1.61 | 1.66 | 3,700 | |
| 09/17/2024 | 1.59 | 1.64 | 1.54 | 1.64 | 22,200 | |
| 09/16/2024 | 1.59 | 1.59 | 1.45 | 1.54 | 16,400 | |
| 09/13/2024 | 1.60 | 1.60 | 1.57 | 1.57 | 5,875 | |
| 09/12/2024 | 1.51 | 1.59 | 1.51 | 1.58 | 23,275 | |
| 09/11/2024 | 1.49 | 1.50 | 1.49 | 1.50 | 2,100 | |
| 09/10/2024 | 1.50 | 1.51 | 1.40 | 1.51 | 37,800 | |
| 09/09/2024 | 1.52 | 1.52 | 1.50 | 1.51 | 2,405 | |
| 09/06/2024 | 1.47 | 1.50 | 1.47 | 1.50 | 2,101 |
About Arch Biopartners Stock history
Arch Biopartners investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arch Biopartners will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arch Biopartners stock prices may prove useful in developing a viable investing in Arch Biopartners
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 71.8 M | 41.8 M | |
| Net Loss | -1.3 M | -1.3 M |
Arch Biopartners Stock Technical Analysis
Arch Biopartners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Arch Biopartners Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arch Biopartners' price direction in advance. Along with the technical and fundamental analysis of Arch Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1515 | |||
| Jensen Alpha | 0.4632 | |||
| Total Risk Alpha | 0.0487 | |||
| Sortino Ratio | 0.1413 | |||
| Treynor Ratio | 1.92 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arch Stock Analysis
When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.